Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation events

Abstract Genotype-informed anticancer therapies such as BRAF inhibitors can show remarkable clinical efficacy in BRAF-mutant melanoma; however, drug resistance poses a major hurdle to successful cancer treatment. Many resistance events to targeted therapies have been identified, suggesting a complex...

Full description

Saved in:
Bibliographic Details
Main Authors: Li Chen, Iulian Pruteanu-Malinici, Anahita Dastur, Xunqin Yin, Dennie Frederick, Ruslan I. Sadreyev, Cyril H. Benes
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-86694-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585851672985600
author Li Chen
Iulian Pruteanu-Malinici
Anahita Dastur
Xunqin Yin
Dennie Frederick
Ruslan I. Sadreyev
Cyril H. Benes
author_facet Li Chen
Iulian Pruteanu-Malinici
Anahita Dastur
Xunqin Yin
Dennie Frederick
Ruslan I. Sadreyev
Cyril H. Benes
author_sort Li Chen
collection DOAJ
description Abstract Genotype-informed anticancer therapies such as BRAF inhibitors can show remarkable clinical efficacy in BRAF-mutant melanoma; however, drug resistance poses a major hurdle to successful cancer treatment. Many resistance events to targeted therapies have been identified, suggesting a complex path to improve therapeutics. Here, we showed the utility of a piggyBac transposon activation mutagenesis screen for the efficient identification of genes that are resistant to BRAF inhibition in melanoma. Although several forward genetic screens performed in the same context have identified a broad range of resistance genes that poorly overlap, an integrative analysis revealed a much smaller functional diversity of resistance mechanisms, including reactivation of the MAPK pathway, PI3K-AKT pathway, and Hippo pathway, suggesting that a relatively small number of therapeutic strategies might overcome resistance manifested by a large gene set. Moreover, we illustrated the pivotal role of the Hippo pathway effector TAZ (encoded by the WWTR1 gene) in mediating BRAF inhibition resistance through transcriptional regulation of receptor tyrosine kinases and through interactions with the E3 ubiquitin ligase NEDD4L.
format Article
id doaj-art-7d1d6ee315774d589b0cd6f455ff8219
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-7d1d6ee315774d589b0cd6f455ff82192025-01-26T12:25:59ZengNature PortfolioScientific Reports2045-23222025-01-0115111210.1038/s41598-025-86694-5Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation eventsLi Chen0Iulian Pruteanu-Malinici1Anahita Dastur2Xunqin Yin3Dennie Frederick4Ruslan I. Sadreyev5Cyril H. Benes6Massachusetts General Hospital Cancer Center, Harvard Medical SchoolMassachusetts General Hospital Cancer Center, Harvard Medical SchoolMassachusetts General Hospital Cancer Center, Harvard Medical SchoolMassachusetts General Hospital Cancer Center, Harvard Medical SchoolMassachusetts General Hospital Cancer Center, Harvard Medical SchoolDepartment of Molecular Biology, Massachusetts General Hospital, Harvard Medical SchoolMassachusetts General Hospital Cancer Center, Harvard Medical SchoolAbstract Genotype-informed anticancer therapies such as BRAF inhibitors can show remarkable clinical efficacy in BRAF-mutant melanoma; however, drug resistance poses a major hurdle to successful cancer treatment. Many resistance events to targeted therapies have been identified, suggesting a complex path to improve therapeutics. Here, we showed the utility of a piggyBac transposon activation mutagenesis screen for the efficient identification of genes that are resistant to BRAF inhibition in melanoma. Although several forward genetic screens performed in the same context have identified a broad range of resistance genes that poorly overlap, an integrative analysis revealed a much smaller functional diversity of resistance mechanisms, including reactivation of the MAPK pathway, PI3K-AKT pathway, and Hippo pathway, suggesting that a relatively small number of therapeutic strategies might overcome resistance manifested by a large gene set. Moreover, we illustrated the pivotal role of the Hippo pathway effector TAZ (encoded by the WWTR1 gene) in mediating BRAF inhibition resistance through transcriptional regulation of receptor tyrosine kinases and through interactions with the E3 ubiquitin ligase NEDD4L.https://doi.org/10.1038/s41598-025-86694-5BRAF inhibitor resistanceTransposon mutagenesis screenHippo pathwayTAZNEDD4L
spellingShingle Li Chen
Iulian Pruteanu-Malinici
Anahita Dastur
Xunqin Yin
Dennie Frederick
Ruslan I. Sadreyev
Cyril H. Benes
Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation events
Scientific Reports
BRAF inhibitor resistance
Transposon mutagenesis screen
Hippo pathway
TAZ
NEDD4L
title Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation events
title_full Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation events
title_fullStr Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation events
title_full_unstemmed Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation events
title_short Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation events
title_sort transposon mediated functional genomic screening for braf inhibitor resistance reveals convergent hippo and mapk pathway activation events
topic BRAF inhibitor resistance
Transposon mutagenesis screen
Hippo pathway
TAZ
NEDD4L
url https://doi.org/10.1038/s41598-025-86694-5
work_keys_str_mv AT lichen transposonmediatedfunctionalgenomicscreeningforbrafinhibitorresistancerevealsconvergenthippoandmapkpathwayactivationevents
AT iulianpruteanumalinici transposonmediatedfunctionalgenomicscreeningforbrafinhibitorresistancerevealsconvergenthippoandmapkpathwayactivationevents
AT anahitadastur transposonmediatedfunctionalgenomicscreeningforbrafinhibitorresistancerevealsconvergenthippoandmapkpathwayactivationevents
AT xunqinyin transposonmediatedfunctionalgenomicscreeningforbrafinhibitorresistancerevealsconvergenthippoandmapkpathwayactivationevents
AT denniefrederick transposonmediatedfunctionalgenomicscreeningforbrafinhibitorresistancerevealsconvergenthippoandmapkpathwayactivationevents
AT ruslanisadreyev transposonmediatedfunctionalgenomicscreeningforbrafinhibitorresistancerevealsconvergenthippoandmapkpathwayactivationevents
AT cyrilhbenes transposonmediatedfunctionalgenomicscreeningforbrafinhibitorresistancerevealsconvergenthippoandmapkpathwayactivationevents